{
    "Company Name": "Mankind Pharma IPO",
    "IPO_Date": "Apr 25, 2023 to Apr 27, 2023",
    "Listing_Date": "Tuesday, 9 May 2023",
    "Face_Value": "1 per share",
    "Price": "1026 to 1080 per share",
    "Lot_Size": "13 Shares",
    "Total_Issue_Size": "40,058,844 shares (aggregating up to 4,326.36 Cr)",
    "Offer_for_Sale": "40,058,844 shares of 1 (aggregating up to 4,326.36 Cr)",
    "Issue_Type": "Book Built Issue IPO",
    "Listing_At": "BSE, NSE",
    "Anchor_Investor_Shares_Offered": "12,017,652 (30.00%)",
    "QIB_Shares_Offered": "8,011,769 (20.00%)",
    "NII_(HNI)_Shares_Offered": "6,008,827 (15.00%)",
    "Retail_Shares_Offered": "14,020,596 (35.00%)",
    "Total_Shares_Offered": "40,058,844 (100%)",
    "Bid_Date": "Apr 24, 2023",
    "Shares_Offered": "12,017,652",
    "Anchor_Portion_Size_(In_Cr.)": "1,297.91",
    "Anchor_lock-in_period_end_date_for_50%_shares_(30_Days)": "Jun 14, 2023",
    "Anchor_lock-in_period_end_date_for_remaining_shares_(90_Days)": "Sep 8, 2023",
    "Event": "Tentative Date",
    "Opening_Date": "Tuesday, 25 April 2023",
    "Closing_Date": "Thursday, 27 April 2023",
    "Basis_of_Allotment": "Wednesday, 3 May 2023",
    "Initiation_of_Refunds": "Thursday, 4 May 2023",
    "Credit_of_Shares_to_Demat": "Friday, 5 May 2023",
    "Cut-off_time_for_UPI_mandate_confirmation": "5 PM on Apr 27, 2023",
    "Application": "Amount",
    "Retail_(Min)": "14,040",
    "Retail_(Max)": "196,560",
    "S-HNI_(Min)": "210,600",
    "S-HNI_(Max)": "996,840",
    "B-HNI_(Min)": "1,010,880",
    "Lot_Size_Calculator": "Lot Size Calculator",
    "Pre_Issue_Share_Holding": "79.00%",
    "Post_Issue_Share_Holding": "76.50%",
    "KPI": "Values",
    "P/E_(x)": "32.5",
    "Market_Cap_(â‚¹_Cr.)": "43263.6",
    "ROE": "27.60%",
    "ROCE": "26.10%",
    "EPS_(Rs)": "33.2",
    "RoNW": "27.70%",
    "Review_By": "Avoid",
    "Brokers": "0",
    "Members": "12"
}